Skip to Content

Medibank Private Ltd

MPL: XASX (AUS)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
A$5.70TfwhlqMbpfyyf

Medibank’s Moat Is Attracting New Policyholders; FVE Increased to AUD 3.10

We increase our Medibank fair value estimate by 7% to AUD 3.10 on more positive policyholder growth assumptions. We are not increasing our assumption of the size of the market, simply that Medibank can take more share. We now assume Medibank can grow policyholders around 3% per year out to fiscal 2025, compared with around 2% previously. With the market estimated to grow at 1% per year, this reflects our expectation that Medibank’s market share edges up to 30% by fiscal 2025 from an estimated 27.2% currently.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of MPL so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center